Get 50% OFF This Monsoon!

Advertisement
AdvertisementAdvertisement
logo

Krishna Institute of Medical Sciences

KIMS
Small Cap
(%) 1D
no_data

No Data Available

1D1W1M3M6M1YMAX

Investor Sentiment

50%50%
Bullish
Bearish
Advertisement
AdvertisementAdvertisement

Krishna Institute of Medical Sciences Share price and Fundamental Analysis

View All Details
View All Details
Krishna Institute of Medical Sciences Limited (KIMS) was incorporated as Jagjit Singh and Sons Private Limited', a Private Limited Company on July 26, 1973 in Mumbai. Subsequently, name of the Company was changed to Krishna Institute of Medical Sciences Private Limited' on January 2, 2004. Pursuant to the conversion of Company to a Public Limited Company, the name was changed to Krishna Institute of Medical Sciences Limited' on January 29, 2004.
Company Incorporation1973
ChairmanBhaskara Rao Bollineni
Head QuartersSecunderabad
Previous NameNA

Key Metrics

Market Cap (Cr)
27,069
PE Ratio
71.89
Industry P/E
63.46
PEG Ratio
0.14
ROE
17.99%
ROCE
13.49%
ROA
7.23%
Total Debt (Cr)
708
Debt to Equity
1.2
Dividend Yield
0%
EPS
9.41
Book Value & P/B
54.18 x 12.49
Face Value
2
Outstanding Shares(Cr)
40.01
Current Ratio
1.23
EV to Sales
9.41

Included In

+More

Stock Returns

1 Week+4.32%
1 Month+3.45%
6 Months+13.6%
1 Year+62.34%
3 Years+179.42%
5 Years+239.41%
no_data

No Stocks

Smart Score

2.5
icn

Unlock Smart Score

See Detailed Analysis & Insights

icn

Unlock Insights

See Detailed Analysis & Insights

Technicals

Returns Calculator

If you would have invested
In 5 years the current value would be
NaNCRNaNCR( %)

Research Report

No Research Report

View Other Reports >

Corporate Action

Board-Meetings
Board-Meetings
Dividends
Bonus
Splits
Right-issues
AGM-EGM
Bulk-Deal
Block-Deal

Financials

Half Yearly Statement

/ View Standalone
PARTICULARS

Total Revenue

Total Expenses

Operating Expense

Operating Profit

Interest

Depreciation & Amortization

Profit Before Tax

Tax

Profit after tax

Adj EPS in Rs - Basic

Adj EPS in Rs - Diluted

Profit and Loss Statement

/ View Standalone
Credit Rating
Director Report
Chairman Report
Auditor Report

Balance sheet

/ View Standalone

Cashflow Statement

/ View Standalone
Mar 25

Promoters : 38.82%

FIIs : 15.45%

DIIs : 31.95%

Public : 13.78%

Promoter
FII/FPI
DII
Public
Promoter Pledge stands at 12.03% of holding in March 2025 Qtr
FII Shareholding Decreased by 0.23% to 15.45% in March 2025 Qtr
DII Shareholding Decreased by 0.09% to 31.95% in March 2025 Qtr

Top Shareholders

View all Share Holders

Key Ratios

Profitability
Valuation
Liquidity

ROE

Avg ROE (3 Yrs) : NaN%

ROCE

Avg ROCE (3 Yrs) : NaN%

ROA

Avg ROA (3 Yrs) : NaN%

NPM

Avg NPM (3 Yrs) : NaN%

Dividend History

Krishna Institute of Medical Sciences Competitors

Sector
Industry

Company Name

MCap(TTM)

PE(TTM)

P/B(TTM)

ROE(TTM)

D/E

Current Ratio(TTM)

5 Year FactSheet

Profitability
Profitability
Growth Ratios
Valuation Ratios
Cashflow Ratios
Debt and Liquidity
Efficiency Ratios

Documents

Annual Reports
Con-Call

News

Krishna Institute of Medical Sciences Management and History

Company Management

icn

Unlock Management Data

See Detailed Analysis & Insights

Company History

Krishna Institute of Medical Sciences Limited (KIMS) was incorporated as Jagjit Singh and Sons Private Limited', a Private Limited Company on July 26, 1973 in Mumbai. Subsequently, name of the Company was changed to Krishna Institute of Medical Sciences Private Limited' on January 2, 2004. Pursuant to the conversion of Company to a Public Limited Company, the name was changed to Krishna Institute of Medical Sciences Limited' on January 29, 2004.

The Company is one of the largest corporate groups in India, with hospitals in Telangana, Andhra Pradesh & Maharashtra providing multi-disciplinary integrated services with a focus on tertiary and quaternary healthcare at affordable cost. It operate 12 multispecialty hospitals under the 'KIMS Hospitals' brand, with an aggregate capacity of over 4,000 beds. It offer a comprehensive range of healthcare services in over 40 specialties and super specialties, including cardiac sciences, oncology, neurosciences, gastric sciences, orthopaedics, organ transplantation, renal sciences and mother & child care.

Until the year 2003, the Company was owned, managed and controlled by Jagjit Singh and certain of his family members, who together owned the entire shareholding of the Company. In February 2003, acting in pursuance of the Takeover MoU, certain of its Promoters, namely Dr. Bhaskar Rao Bollineni, Krishnaiah Bollineni and BRMH, along with certain other individuals and entities, acquired the entire equity share capital of the Company.

Led by Dr. Bhaskar Rao Bollineni, Managing Director and CEO of the Company, a renowned cardiothoracic surgeon, it has grown from a single hospital to a chain of multispecialty hospitals, both organically and through strategic acquisitions. The oldest hospital in their network was established in 2000 at Nellore, by its Corporate Promoter, BRMH, with a capacity of approximately 200 beds and, At present, the hospital network has grown to six multispecialty hospitals in six cities, with a total capacity of 2,120 beds, including 1,705 operational beds.

The Hospitals are equipped with state-of-the-art medical equipment and employ practices and policies which help to provide quality healthcare services to their patients. It was one of the first hospitals in Hyderabad to install 4-Arm HD da Vinci Robot technology at Secunderabad hospital. The flagship hospitals at Secunderabad and Rajahmundry have been accredited by the National Accreditation Board for Hospitals and Healthcare Providers, India ('NABH'). The Hospital at Secunderabad is accredited with ISO 9001:2008 certification and has also been accredited by the National Accreditation Board for Testing and Calibration Laboratories ('NABL'). The Hospital situated at Secunderabad was awarded the Healthcare Excellence Award', by the Indo Global Healthcare Summit and Expo, in 2015. It has also received awards from the Association of Healthcare Providers (India) ('AHPI') for nursing excellence, in 2015 and for Patient Friendly Hospital', in 2017. In 2017, it was awarded the best hospital of the year in the multispecialty hospital category in Hyderabad by Times Healthcare Achievers Awards and in 2016 received the Pharmacie DeQualite certification from Bureau Veritas. Further, it was the first hospital in Andhra Pradesh and Telangana to have been Green OT certified in 2016. It is also the laureate of the Asia Pacific Society of Infection Control CSSD Center of Excellence Silver Award 2015-2016. Neurology India Journal has ranked the neurology department at its hospital at Secunderabad as the third biggest centre in India on the basis of volume of epilepsy surgeries performed, as on July 31, 2016.

In addition to healthcare services, the company also conduct medical education programmes through its affiliations with state medical boards and universities, for various broad and super specialties at its hospitals in Secunderabad and Rajahmundry, including for DNB, under graduation, post-graduation, PhD and diploma programmes. It is also affiliated with Kaloji Narayana Rao University of Health Sciences and the Andhra Pradesh Para Medical Board.

During 2022, Sunshine Hospitals became subsidiary of the Company effective from April, 2022.

In 2022-23, the Company opened an exclusive Gastroenterology unit at Vizag.

During FY 2022-23, Sarvejana Healthcare Private Limited became a Subsidiary of the Company effective 01st April 2022; SPANV Medisearch Lifesciences Private Limited became the Subsidiary of Company on 01.09.2022. Suryateja Healthcare Private Limited has ceased to be step down subsidiary of the Company w.e.f. December 01, 2022.

Krishna Institute of Medical Sciences Share Price

Krishna Institute of Medical Sciences share price reflects investor sentiment toward the company and is impacted by various factors such as financial performance, market trends, and economic conditions. Share price is an indicator which shows the current value of the company's shares at which buyers or sellers can transact.

Krishna Institute of Medical Sciences Market Cap

Market capitalization of Krishna Institute of Medical Sciences indicates the total value of its outstanding shares. Marketcap is calculated by multiplying share price and outstanding shares of the company. It is a helpful metric for assessing the company's size and market Valuation. It also helps investors understand how Krishna Institute of Medical Sciences is valued compared to its competitors.

Krishna Institute of Medical Sciences PE Ratio

Krishna Institute of Medical Sciences PE ratio helps investors understand what is the market value of each stock compared to Krishna Institute of Medical Sciences 's earnings. A PE ratio higher than the average industry PE could indicate an overvaluation of the stock, whereas a lower PE compared to the average industry PE could indicate an undervaluation.

Krishna Institute of Medical Sciences PEG Ratio

The PEG ratio of Krishna Institute of Medical Sciences evaluates its PE ratio in relation to its growth rate. A PEG ratio of 1 indicates a fair value, a PEG ratio of less than 1 indicates undervaluation, and a PEG ratio of more than 1 indicates overvaluation.

Krishna Institute of Medical Sciences ROE (Return on Equity)

Return on Equity (ROE) measures how effectively Krishna Institute of Medical Sciences generates profit from shareholders' equity. A higher ROE of more than 20% indicates better financial performance in terms of profitability.

Krishna Institute of Medical Sciences ROCE (Return on Capital Employed)

Return on Capital Employed (ROCE) evaluates the profitability of Krishna Institute of Medical Sciences in relation to its capital employed. In simple terms, ROCE provides insight to investors as to how well the company is utilizing the capital deployed. A high ROCE of more than 20% shows that the business is making profitable use of its capital.

Krishna Institute of Medical Sciences Total Debt

Total debt of Krishna Institute of Medical Sciences shows how much the company owes to either banks or individual creditors. In simple terms, this is the amount the company has to repay. Total debt can be a very useful metric to show the financial health of the company. Total debt more than equity is considered to be a bad sign.

Krishna Institute of Medical Sciences Debt to Equity Ratio

The Debt-to-Equity (DE) ratio of Krishna Institute of Medical Sciences compares its total debt to shareholders' equity. A higher Debt to Equity ratio could indicate higher financial risk, while a lower ratio suggests that the company is managing its debt efficiently.

Krishna Institute of Medical Sciences CAGR (Compound Annual Growth Rate)

CAGR shows the consistent growth rate of Krishna Institute of Medical Sciences over a specific period, whether it is over a month, a year, or 10 years. It is a key metric to evaluate the company’s long-term growth potential. Main metrics for which CAGR is calculated are net sales, net profit, operating profit, and stock returns.

Krishna Institute of Medical Sciences Technical Analysis

Technical analysis of Krishna Institute of Medical Sciences helps investors get an insight into when they can enter or exit the stock. Key components of Krishna Institute of Medical Sciences Technical Analysis include:

Support Levels (S1, S2, S3)

There are usually multiple support levels, but the main support levels for a stock are S1, S2, S3. Support levels indicate price points where stock might get support from buyers, helping the stock stop falling and rise.

Resistance Levels (R1, R2, R3)

There are usually multiple resistance levels, but the main resistance levels for a stock are R1, R2, R3. Resistance levels represent price points where Krishna Institute of Medical Sciences shares often struggle to rise above due to selling pressure.

Krishna Institute of Medical Sciences Dividends

Dividends refer to the portion of the company’s profits distributed to its shareholders. Dividends are typically paid out in cash and reflect Krishna Institute of Medical Sciences ’s financial health and profitability.

Krishna Institute of Medical Sciences Bonus Shares

Bonus shares are usually given by companies to make the stock more affordable, increase liquidity, boost investor confidence, and more.

Krishna Institute of Medical Sciences Stock Split

Stock split increases the number of its outstanding shares by dividing each existing share into multiple shares. When the company offers a stock split, the face value of the stock reduces in the same proportion as the split ratio.

Krishna Institute of Medical Sciences Financials

The financials of Krishna Institute of Medical Sciences provide a complete view to investors about its net sales, net profit, operating profits, expenses, and overall financial health. Investors can analyze financial data to assess the company’s stability and also understand how the company has been growing financially.

Krishna Institute of Medical Sciences Profit and Loss Statements

The profit and loss statement of Krishna Institute of Medical Sciences highlights its net sales, net profit, total expenditure, and operating profits in the current financial year. This Profit and Loss statement is crucial for evaluating the profitability and financial stability of Krishna Institute of Medical Sciences .

Krishna Institute of Medical Sciences Balance Sheet

The balance sheet presents a snapshot of Krishna Institute of Medical Sciences ’s assets, liabilities, and equity of shareholders, providing insights into the financials of the company.

Krishna Institute of Medical Sciences Cashflow Statements

Cashflow statements track the company's cash inflows and outflows over a period. It is an essential tool for understanding how well the company manages its liquidity and finances.